Drug discrimination methods in human drug abuse liability evaluation-Reference-Cited by-同舟云学术

Drug discrimination methods in human drug abuse liability evaluation

Published:1991-12 Issue:12 Volume:86 Page:1587-1594
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

PRESTON KENZIE L.

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1360-0443.1991.tb01752.x/fullpdf

Reference34 articles.

1. Double-blind Evaluation of Reinforcing and Anorectic Actions of Weight Control Medications

2. G. E. Bigelow, K. L. Preston, and I. A. Liebson(1991 ) Effects of pentazocine, nalbuphine and buprenorphine in humans trained to discriminate among saline, hydromorphone and butorphanol. Presented at the Fifty-Third Annual Scientific Meeting of the Committee on Problems of Drug Dependence, Inc., at Palm Beach, Florida, USA (June, 1991).

3. Testing Drugs for Physical Dependence Potential and Abuse Liability: NIDA Research Monograph 52

4. Discriminative stimulus and subjective effects of smoked marijuana in humans

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Threshold dose for discrimination of nicotine via cigarette smoking;Psychopharmacology;2016-04-02

2. Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs;The Behavioral Neuroscience of Drug Discrimination;2016

3. Clinical Evaluation of Abuse Potential for New Pharmaceuticals;Nonclinical Assessment of Abuse Potential for New Pharmaceuticals;2015

4. Relationship between drug discrimination and ratings of subjective effects;Behavioural Pharmacology;2013-09

5. Nicotine Discrimination in Humans;Drug Discrimination;2011-10-24